跳至主要内容
临床试验/CTRI/2024/08/072215
CTRI/2024/08/072215尚未招募2/3 期

A prospective clinical study to determine the therapeutic dose of Centchroman in the manangement of cyclical mastalgia

Uttar Pradesh University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年8月19日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Symptomatic relief from cyclical mastalgia.

研究概览

简要总结

Trial is still running and we have still not completed total no of participants

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
15.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • All women with mastalgia with VAS score ≥3 lasting for more than 5-7 days per cycle were included after signing a consent form.

排除标准

  • • Patients with polycystic ovarian diseases and uterine cervical hyperplasia.
  • • First six months of Lactation and pregnancy • Patients who were not giving consent.
  • • Past history of breast carcinoma or family history of breast carcinoma • Patient who were planning for pregnancy .
  • • Women suspected or diagnosed of malignancy • Recent history of jaundice or hepatic impairment.
  • • Severe allergic states.
  • • History of thrombosis.

结局指标

主要结局

Symptomatic relief from cyclical mastalgia.

时间窗: Outcome will be assessed at 4,8,12 and 24 weeks

次要结局

  • Improvement in fibroadenosis as well as reduction in size of fibroadenoma.(Outcome will be assessed at 4,8,12 & 24 weeks)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dharmendra Tarkar

UPUMS SAIFAI ETAWAH

研究点 (1)

Loading locations...

相似试验